Talk with an Information Specialist



Talk to an information specialist today!
1-855-PCC-INFO (1-855-722-4636)
support@prostatecancer.ca

Are you or a loved one facing a recent prostate cancer diagnosis? Looking for information? Wondering what support programs and resources are available to you? Prostate Cancer Information Service can help

 

What is the PCIS?

The Prostate Cancer Information Service (PCIS) is a helpline with information specialists on the line who will provide support and answer your prostate cancer questions through phone or email.

This confidential and reliable service is available in a number of languages.

Who can use the PCIS?

The PCIS is available for everyone, including:

  • men with prostate cancer
  • a patient’s circle of care (partners, caregivers, family, friends)
  • the general public
  • healthcare professionals

What are the benefits of using PCIS?

  • Free: you can use this service for free.
  • Reliable: all of the information provided is evidence-based and reliable.
  • Flexible: the service is available Monday-Friday 9 a.m. to 7:00 p.m. EST. You can be on the phone for 5 minutes or as long as you need to, to get your questions answered.
  • Convenient: you can call of email from the comfort of your home.

Get your questions answered!

Talk to an information specialist today:

This service is available Monday to Friday 9 a.m. to 7:00 p.m. EST.

The Prostate Cancer Information Service is provided by Prostate Cancer Canada in partnership with the Canadian Cancer Society.

For more information and support:





Subscribe to our free monthly e-newsletter!

* indicates required

 





 
PCC Spotlight
Rocco Rossi to wrap up successful 5-year tenure as Prostate Cancer Canada CEO

September 7, 2017 - TORONTO, ON - With mixed emotions, longstanding Prostate Cancer Canada (PCC) President and CEO, Rocco Rossi, formally announced today that his time leading the organization will officially come to a close as of December 31, 2017.
More

Mutation in prostate tumours shown to change epigenetic identity, the make-up of DNA

(TORONTO, Canada - Aug 7, 2017) -- Prostate cancer researchers have mapped the impact of an acquired mutation that alters epigenetic identity, the make-up of DNA, in about 50% of patient tumour samples.
More

Movember Foundation and Prostate Cancer Canada team up to turn research into results

July 26, 2017 - TORONTO, ON - Continuing their longstanding tradition of partnering to fund high quality Canadian prostate cancer research, Prostate Cancer Canada (PCC) and The Movember Foundation today announced two new projects with very real potential to make a tangible difference in the lives of men living with aggressive forms of prostate cancer.
More


Click here for news archive